Publications

Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.

Dowdy, DW; GRANT, AD; DHEDA, K; Nardell, E; FIELDING, K; MOORE, DA J;

2017

The Journal of infectious diseases, (2017).216 suppl_ 10.1093/infdis/jix320.

The sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis.

Telisinghe, L; Amofa-Sekyi, M; Maluzi, K; Kaluba-Milimo, D; Cheeba-Lengwe, M; Chiwele, K; KOSLOFF, B; FLOYD, S; Bailey, S-L; AYLES, H;

2017

The international journal of tuberculosis and lung disease, (2017).21 6 10.5588/ijtld.16.0764.

Drivers of Tuberculosis Transmission.

Mathema, B; Andrews, JR; Cohen, T; Borgdorff, MW; Behr, M; GLYNN, JR; Rustomjee, R; Silk, BJ; Wood, R;

2017

The Journal of infectious diseases, (2017).216 suppl_ 10.1093/infdis/jix354.

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation.

VASSALL, A; SIAPKA, M; FOSTER, N; Cunnama, L; Ramma, L; FIELDING, K; McCarthy, K; CHURCHYARD, G; GRANT, A; Sinanovic, E;

2017

The Lancet Global health, (2017).5 7 10.1016/S2214-109X(17)30205-X.

Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study.

Van Ingen, J; Kohl, TA; KRANZER, K; Hasse, B; Keller, PM; Katarzyna Szafrańska, A; Hillemann, D; Chand, M; Schreiber, PW; Sommerstein, R; Berger, C; Genoni, M; Rüegg, C; Troillet, N; Widmer, AF; Becker, SL; Herrmann, M; Eckmanns, T; Haller, S; Höller, C; Debast, SB; Wolfhagen, MJ; Hopman, J; Kluytmans, J; Langelaar, M; ... Sax, H.

2017

The Lancet. Infectious diseases, (2017).17 10 10.1016/s1473-3099(17)30324-9.

The optimal design of the stepped wedge trial and a comparison to other trial designs.

THOMPSON, JA; FIELDING, K; HARGREAVES, J; Copas, A;

2017

Trials, (2017).18 1 10.1186/s13063-017-1902-y.

[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].

Feiterna-Sperling, C; Brinkmann, F; Adamczick, C; Ahrens, F; Barker, M; Berger, C; Berthold, LD; Bogyi, M; Von Both, U; Frischer, T; Haas, W; Hartmann, P; Hillemann, D; Hirsch, FW; KRANZER, K; Kunitz, F; Maritz, E; Pizzulli, A; Ritz, N; Schlags, R; Spindler, T; Thee, S; Weizsäcker, K;

2017

Pneumologie (Stuttgart, Germany), (2017).71 10 10.1055/s-0043-116545.

Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.

LANGE, B; KHAN, P; Kalmambetova, G; Al-Darraji, HA; Alland, D; Antonenka, U; Brown, T; Balcells, ME; Blakemore, R; Denkinger, CM; DHEDA, K; Hoffmann, H; Kadyrov, A; Lemaitre, N; Miller, MB; Nikolayevskyy, V; Ntinginya, EN; Ozkutuk, N; Palacios, JJ; Popowitch, EB; Porcel, JM; Teo, J; Theron, G; KRANZER, K;

2017

The international journal of tuberculosis and lung disease, (2017).21 5 10.5588/ijtld.16.0702.

Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life.

Mendy, AL; AGBLA, SC; ODUTOLA, AA; ANTONIO, M; GREENWOOD, BM; SUTHERLAND, JS; Ota, MO C;

2017

PloS one, (2017).12 10 10.1371/journal.pone.0185824.

Language discordance between tuberculosis patients and healthcare providers challenging universal access.

Nakiwala, D; Kellgren, L; Herzmann, C; OLARU, ID; Brown, M; FERRAND, R; KHAN, P; KRANZER, K;

2017

The European respiratory journal, (2017).49 4 10.1183/13993003.00116-2017.